Imidazopyridine derivatives as melancortin receptor agonists

US7495009B2 · kind B2 · utility

Assignee

• Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S) SAS · FR

Inventors

• Lydie Poitout · Antony, FR
• Valerie Brault · Saint-Arnoult-en-Yvelines, FR
• Carole Sackur · Paris, FR
• Pierre Roubert · Paris, FR
• Pascale Plas · Châtillon, FR

Key dates

• Filing date: Mar 29, 2004
• Grant date: Feb 24, 2009
• Expiry date: May 2, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Derivatives of imidazopyridine which have a good affinity for certain sub-types of melanocortin receptors, in particular MC4 receptors and are useful for treating pathological states and diseases in which one or more melanocortin receptors are involved and pharmaceutical compositions containing said products.